COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SLOVENIA

Euromonitor International

January 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Flu Seasons To Drive Future Category Growth

High Pollen Levels Drive Higher Allergy Rates and Sales of Antihistamines/allergy Remedies (systemic)

Competition To Intensify As the Healthcare Budget Tightens

Competitive Landscape

Gsk Consumer Healthcare Retains Its Lead

Top Three Producers Hold Strong Positions

Product Development and Marketing Activity To Gear Up During the Forecast Period

Category Data

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018

Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018

Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018

Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023

Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Executive Summary

Consumer Health Emerges From A Volatile Period, Although Still Not on Stable Ground

Higher Sales Levels Potentially Fuelled by Government Cuts To the Healthcare Budget

Little Change Other Than Increasing Competition

Distribution Channels Limited by Legislation for Most Categories

the Forecast Period Sees A Green Light for OTC Sales

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 8 Life Expectancy at Birth 2013-2018

Market Data

Table 9 Sales of Consumer Health by Category: Value 2013-2018

Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 13 Penetration of Private Label by Category: % Value 2013-2018

Table 14 Distribution of Consumer Health by Format: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format and Category: % Value 2018

Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Definitions

Sources

Summary 1 Research Sources

Coughs, colds and allergies remain the most prevalent reasons for Slovenian consumers to choose self-medication, making this one of the largest OTC categories in terms of value, with strong consecutive value growth over the review period. However parents remain vigilant with their children and generally refrain from this practice and primarily consult with their paediatricians.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Slovenia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.